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Perhaps no criminal justice innova-tion has spread as rapidly in recentyears as drug courts, which offer
judicially monitored treatment as an
alternative to incarceration for non-vio-
lent addicts. The first drug court was
launched in Dade County, Florida, in
1989.  Today, there are more than 1,200
drug courts either in operation or in plan-
ning across the country.  More than
226,000 defendants have participated in
these programs.  
Drug courts are the most prominent
example of a wave of “problem-solving”
innovation that has sought to change the
way courts operate in this country.
Alongside drug courts, domestic violence
courts, community courts, family treat-
ment courts, mental health courts, and
other specialized courts are using the
authority of the judicial branch in new
ways—in an effort to improve outcomes
for victims, communities, and defen-
dants.  These problem-solving courts
employ new tools and new methods—
such as requiring defendants to appear
regularly before judges to report on their
compliance with court orders, or adding
social scientists, drug treatment coun-
selors, and other service providers to the
courtroom team.
The first generation of problem-solv-
ing courts has achieved some provocative
results—none more so than drug courts.
Independent research credits drug courts
with reducing rates of drug use and re-
arrest among participants.  Also, treat-
ment retention rates—a key indicator of
long-term sobriety—are twice as high for
participants in drug courts as opposed to
individuals who seek out treatment vol-
untarily.  
To date, the drug court movement has
largely been a grassroots phenomenon,
driven by a highly motivated cadre of
judges, prosecutors, and court leaders.
Based on the demonstrated success of
drug courts—and the enthusiastic public
attention these courts have generated—a
number of states have begun to take the
next step, seeking not just to replicate
pilot drug courts, but rather to test sys-
tem-wide the viability of new approaches
to the problem of addiction.  Their focus
is on building systems at a state level,
either through special judicial branch-led
efforts (as in New York), legislation
(Indiana), or collaborative efforts that
bring together the heads of statewide
agencies like corrections, courts, and
social services (Utah).  
Clearly, drug courts are at the brink of
moving into a new stage of development.
Acknowledging this reality, in March
2002 the United States Department of
Justice, working with the Center for
Court Innovation, brought together a
select group of judges, practitioners, and
thinkers from around the country to dis-
cuss the future of drug courts.  The goal
of the roundtable was two-fold: first, to
unearth some of the strategic, conceptual,
and practical challenges that practitioners
face in attempting to bring drug courts
into the mainstream of court operations,
and second, to provide a road map to
drug court advocates in addressing those
challenges.  
Perhaps not surprisingly, the topic
proved to be a complicated one.  During
a day-long conversation, court adminis-
trators, judges, legal scholars, and experts
in other fields of social policy innovation
grappled with a series of difficult ques-
tions.  How do you “go to scale” with an
idea like drug courts?  Is the goal to pro-
mote continued replication of the drug
court model?  Or is the goal to advance
drug court principles and strategies, mak-
ing sure they take root in every court-
room?  Most important, how do you
institutionalize innovation?  Will the
drug court approach lose its effectiveness
if it becomes business as usual?
Several key themes emerged from the
discussion.   Many, though not all, partic-
ipants agreed that going to scale meant
more than “hanging more signs on the
door” (a phrase coined by University of
Wisconsin law professor Michael Smith)
or merely increasing the number of drug
courts in existence.  Instead, participants
seemed eager to distill the “active ingre-
dients” or “essence” of the drug court
model—and to encourage the spread of
drug court principles as opposed to
expanding the number of drug courts.
Adele Harrell, a researcher at the Urban
Institute who has written extensively
about drug courts, put it best when she
suggested that success for advocates
might lie in drug courts fading “out of
existence as their tenets become embed-
ded in practice.”  
The desire to spread elements of the
drug court approach—and not replicate
drug courts per se—has some important
implications.  First and foremost, it
means that advocates must identify
which elements of the model that they
wish to see incorporated into the broader
court system.  This is a more difficult task
than it might at first appear.  Participants
at the roundtable articulated a number of
core drug court elements.  For Utah state
court administrator Gary Becker, the
essence of drug courts is the creation of
new partnerships between courts and
state treatment agencies.  For law profes-
sor Smith, it is “the idea that sentencing
is a responsibility of the court over a long
term.”  San Diego Judge James Milliken
and Indianapolis prosecutor Scott
Newman cited concrete goals: providing
judges with more comprehensive assess-
ments and more sophisticated manage-
ment information tools to guide sentenc-
ing decisions and help track offender
compliance with court orders.  And for
New York Deputy Chief Adminstrative
Judge Joseph Traficanti, who’s leading an
ambitious statewide effort to create drug
courts in each of New York’s 62 counties,
the goal is to make it possible “for any
defendant, in any jurisdiction, to go into
treatment.”  The fact that participants in
the roundtable (most of them drug court
proponents) were unable to reach con-
sensus on the core elements of the drug
court approach suggests that more work
has to be done before advocates attempt
to mainstream them.
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In addition to tackling conceptual
problems, participants also addressed
strategy questions.  Participants returned
again and again to the challenge of insti-
tutionalizing the drug court model with-
out dampening the spirit of innovation
that led to their creation in the first place.
“[P]eople don’t respond well to being
told, ‘You have to do this,’” said Lisbeth
Schorr, an expert on social policy innova-
tion based at Harvard University.  She
added: “You can’t mandate belief in a pro-
gram.” Indianapolis prosecutor Scott
Newman agreed, arguing that key leaders
must have “[t]ransformative personal
experiences” if they are to buy into the
drug court idea.
Roundtable participants repeatedly
articulated the tension between the need
to ensure quality control as an idea goes
to scale and the imperative to preserve
local flexibility.  One way this was
expressed was the effort to distinguish
“institutionalization” from “bureaucrati-
zation.”  “Bureaucracy creates a coercive
style of leadership that forces other people
to act in a certain way,” Scott Newman
said, while “institutionalization is a moti-
vational style of leadership which gets
people inspired.” Many participants
argued that the best way to promote insti-
tutionalization without bureaucratization
was to create an intermediary entity that
would provide the technical assistance
and support necessary to ensure the qual-
ity of implementation at individual sites.
This would help drug courts “move from
a system based on charisma to one based
on standards and principles,” without
sacrificing local control, according to
Columbia University law professor
Michael Dorf.  
Participants also highlighted the need
for drug courts to create new partnerships
or strengthen existing ones as they
mature.  One example cited was the need
to work with state drug and alcohol agen-
cies, which not only manage large sums of
money (from federal health and human
service grants) but also have responsibil-
ity for guaranteeing the quality of treat-
ment services.  Going to scale will be
“next to impossible” without involving
the commissioners of state alcohol and
drug agencies, said Valerie Raine of the
Center for Court Innovation.  
A second area for potential collabora-
tion are state legislatures, which in many
places are eager to create a statutory
framework (and provide funding) for
drug courts.  Partnerships with state legis-
latures can either help or hinder drug
courts, as the examples of Utah and
Indiana suggest.  While Utah provided a
statutory framework that allowed federal
treatment resources to be redirected to
drug courts—clearly a positive develop-
ment—in Indiana, pending legislation
seeks to codify how drug courts are
defined, a development that many feared
would severely limit local flexibility.  This
suggests that drug court advocates will
have to proceed cautiously in working
with legislatures.
In addition to airing out conceptual
and strategic challenges, participants
shared their reservations about institu-
tionalization—and in particular its poten-
tial unintended consequences.  “Today’s
innovation is tomorrow’s conventional
wisdom,” warned Michael Smith.  “I think
we need to find a way to go to scale that’s
open to constant change, revision and dis-
covery.  Otherwise, you just make it more
difficult for the next innovator.”  In that
vein, Adele Harrell cautioned against
“overselling the promise” of drug courts,
a shortcoming of past criminal justice
innovations that have come and gone. 
Despite these reservations, participants
were cautiously optimistic about the
prospects for institutionalization, point-
ing out that drug courts have already
made significant strides forward.  Perhaps
the most heartening news of the day came
from Lisbeth Schorr.  Schorr, who has
spent the greater part of her professional
life thinking about government innova-
tion, remarked that in discussing drug
court institutionalization, participants
had already reached an unusual level of
sophistication.  “[T]his is a far better,
more rigorous discussion than I am used
to hearing,” she said. 
What follows is an edited transcript of
the discussion, which took place over six
hours in a conference room in
Washington, D.C.
SETTING THE STAGE
Francis Hartmann: Where are drug
courts in the “going to scale” process?
Greg Berman: I want to read two quotes
that I think speak directly to that ques-
tion.  The first is from John Goldkamp, a
researcher at Temple University, speaking
about drug courts: “What we have now is
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DISCUSSION PARTICIPANTS
not a bunch of little hobbies that judges
have in isolated jurisdictions, but rather a
paradigm shift that larger court systems
are trying to come to grips with.  The
question isn’t, ‘Are the courts supposed to
be doing this?’ It’s, ‘What are you going to
do about it? How does it fit in?’ It’s no
longer a question of whether this should
be invented.” The second is from Michael
Smith, who’s here with us today.  He says,
“It seems to me there are two different
ways to go to scale.  One is to use prob-
lem-solving courts as laboratories to
improve the way they do business.  The
other is to build a new system devoted to
proliferating problem-solving courts.
That choice may turn out to be critical.”
These two statements underline the
theme for today’s conversation—an
acknowledgment that drug courts are
attempting to move from the margins of
the court system to the mainstream.  I
think the challenge is: how do you go to
scale in a way that is thoughtful and
deliberate?
Marilyn McCoy Roberts: When the
Department of Justice got into the busi-
ness of supporting drug courts in 1994,
there were about 30 or 40 drug courts
around the country.  Today we’re nearly
to the 800 mark and have quite a few
more—400 or so—in the planning stages.
What’s remarkable is that drug courts,
which initially didn’t attract much inter-
est from court administrators, have now
been embraced by the leadership of court
systems around the country. 
James Milliken: One problem that going
to scale will hopefully address is the
exclusion of populations that need our
services the most.  For example, federal
and state grants for juveniles exclude kids
who have been violent or who have gang
associations.  Now that we know the
medicine works, we need to expand the
system so that we can provide the medi-
cine to everybody who needs it.
Joseph Traficanti, Jr.: I think institution-
alization does mean, at least in part, the
creation of more drug courts.  I see it as a
fundamental issue of fairness: two people
arrested in different places for the same
crime should have the same opportunity
for treatment.
Michael Smith: For me, the question is:
what are we taking to scale?  The answer
can’t simply be to put more signs on the
door.  We have to know what the active
ingredient of innovation is.  Otherwise
we won’t be able to spread the idea.  
ANALOGIES
Hartmann: Drug courts are not the first
criminal justice innovation to attempt to
go to scale.  What have we learned from
other efforts in the field? 
Smith: Let me offer two examples.  The
first is pretrial diversion programs devel-
oped in the 1960s.  Public and profes-
sional opinion supported this idea, and it
quickly became the norm.  But nobody
had really done the research to under-
stand whether the program had the
desired effects.  Ten years later, when we
finally did the research, we found that the
diversions made no difference in out-
comes.  The second example is point
scales for the bail system.  In the 1980s, I
was visiting another state and came under
attack for a point scale they’d instituted
that wasn’t working.  I was told they’d
come up with the scale based on an arti-
cle I’d written about the Manhattan bail
project in 1960.  I said, “It’s 1980.  This is
a different state.  And we abandoned that
scale in 1970 because we found it had no
empirical basis.  What are you doing?” 
John Stuart: As a defender, I can tell you
that my clients were being denied bail
based on that point scale all through the
1980s in Minnesota.  It’s unfortunate that
we didn’t have this conversation 20 years
earlier!
Smith: The lesson I’m trying to highlight
here is the danger of replicating a specific
model to another context.  If you want to
go to scale, you’ve got to know why, and
you’ve got to be very careful to avoid
harm creation.
Hartmann: Mike Scott, what can you tell
us about your experience with problem-
oriented policing?
Michael Scott: We’ve had some success
in getting police officers to do beat-level
problem-solving, using street savvy, com-
mon sense, and some rudimentary statis-
tical analysis to target local concerns.
We’ve had less success with higher-level
problem-solving, applying more rigorous
research methods to study a class of prob-
lems experienced across a whole jurisdic-
tion.  A police agency’s enthusiasm for
problem-solving tends to wax and wane
with the arrival and departure of individ-
ual champions within the department—
when the champions leave, the innova-
tion disappears as well.  Many people still
cling to fairly simple notions of what
police departments can do, with no sense
of what a broad range of responses could
really be possible.  Problem-oriented
policing remains optional; it has not been
institutionalized.  One reason this is so is
that there is no external constituency say-
ing, “Give us more of that problem-solv-
ing stuff.” 
Hartmann: Is there a tension between try-
ing to turn each police officer into a mini-
problem-solving unit unto himself versus
trying to arm departments with better
analytical and research tools to problem-
solve on a higher level?
Scott: So far, the funding has been geared
toward line officers who want to go forth,
do good, and interact with the commu-
nity.  Unfortunately, that’s a heck of a lot
more politically appealing than the idea
of hiring a bunch of research analysts
who work back at headquarters to study
community problems.  And I think it’s
fair to say that line-level cops have held
up their end of the problem-oriented
policing bargain a lot better than the
police executives have.  In fact, we have
line officers to thank for much of the
replication that we have seen. Policing is
a profession that relies heavily on oral tra-
dition, cops learn from talking to one
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another.  We’ve come to the conclusion
that stories are the best training tool—so
at our annual conferences, cops spend the
bulk of their time sharing examples of
what they’re doing.  If you can get enough
of the individual stories out, you can
build a critical mass of support for a new
idea like problem-oriented policing—or
drug courts, for that matter.
Hartmann: Are there other criminal jus-
tice analogies out there?
Stuart: To me, the inescapable historical
analogy is the juvenile court movement,
which succeeded spectacularly in going
to scale.  The first juvenile court opened
in 1899; every state had one within about
twenty years. The most prominent prob-
lems with juvenile courts—as they
became widespread and institutional-
ized—were lack of due process, poor fact
finding, indefinite jurisdiction over peo-
ple based on a small offense, and idiosyn-
cratic judging.  It was a lawless court.  As
we develop drug courts, we need to keep
this experience in mind.
Smith: It might also be useful to bear in
mind that in its earlier days, the juvenile
court was a mechanism thought to be use-
ful in controlling immigrant populations.
It was a strategy for dealing with groups
that were marginalized, and making sure
they stayed that way.  If drug courts are
falling into that part of the pattern, we
may want to be very careful to leave this
form of social control behind when we
take them to scale.  One way to avoid that
problem is to bring drug courts to white
university towns and suburbs, thereby
legitimizing a system which is currently so
pointed at African-American youth.
Scott Newman: I have a different take on
the issue of race.  What we’ve found is
that young African-American males are
opting out of drug court at a dispropor-
tionate rate; they are more likely to say,
“I’ll do my time instead.” They simply
aren’t as fearful of the conventional sys-
tem. 
Hartmann: We’ve brought some outsiders
to this discussion—experts who have
been involved in taking innovative pro-
grams to scale in fields other than crimi-
nal justice.  What have you heard so far?
What lessons can you draw out for us?
Lisbeth Schorr: I see five key lessons
regarding how to go to scale.  The first is
the need to distill the essence of an inno-
vation. Unless you spell out what you’re
doing with some specificity, you can’t
spread the model.  Another lesson is
attention to those elements that don’t
travel easily from site to site.  In many
programs I’ve looked at, one of the essen-
tial components is the practitioners’ belief
in what they’re doing.  You can’t mandate
belief in a program when you replicate or
systematize it, but you must take belief
into account through training.  The third
point is recognizing the importance of
context.  In my experience, the biggest
mistake of replicators is thinking that
because their program is wonderful, the
surroundings won’t destroy it when they
plunk it down in a new place.  But the
surroundings do destroy the program
unless you provide high-quality training.
The context is the most likely saboteur of
the spread of good innovations. Part of
the context that can undermine innova-
tion is the demand for evidence, and what
that demand does to the innovation itself.
The demand for proof by funders, elected
officials, and others has led practitioners
to look for outcomes that are easy to mea-
sure rather than the outcomes they’re
really after.  The fourth point is that prac-
titioners should arm themselves to look
for patterns rather than proof.  As you
begin to notice patterns that reappear
when you have success, and as those
observations accumulate, you can start to
offer some very persuasive evidence, if
not “proof,” of what works.  Finally,
almost all successful scale-up efforts I’ve
seen have had an intermediary organiza-
tion to provide legitimization and to artic-
ulate the essence of the program to be
replicated. The importance of an interme-
diary cannot be underestimated. 
Bernardine Watson: At Public/Private
Ventures, we’re very interested in alterna-
tive strategies for working with high-risk
youth.  We’ve developed three kinds of
criteria for determining whether a pro-
gram is ready for replication.   The first is
the program itself, and whether it actually
addresses the recognized need or prob-
lem.  Clearly this isn’t an issue for drug
courts.  The second is whether it does so
through methods that are considered
credible by the field.  Finally—and this is
the thorny area that Lee Schorr talked
about—we ask whether the program has
proof of success and measurable results.
The social service field has set a very high
bar for how to prove that a program
works: often the field requires a random
assignment study to determine success.
But very few programs can muster this
kind of data.  We were able to do it in the
case of Big Brothers, Big Sisters, an orga-
nization with a well-defined model, a
name brand, and funders willing to invest
the money necessary for long-term and
very expensive research.
Schorr: In the last 20 years, the rhetoric
in the field has really improved.
Everyone knows what they’re supposed
to say about their program.  But that
doesn’t mean they’re actually doing it.
Another function that an intermediary
can play is to go beyond rhetoric in ana-
lyzing what makes a program work.  
ASSETS
Hartmann: Are there reasons to be opti-
mistic about the prospects of drug court
institutionalization? Do courts bring any
particular assets to the business of going
to scale?
Eric Lane:  The evolution of unified state
court systems is one important asset,
because it has allowed the judiciary to
become a real branch of government in
the sense that it can assign resources, del-
egate responsibilities, and make things
like drug courts happen that never would
have been possible 25 years ago. 
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Hartmann: I would nominate a few more
assets.  One is that the judicial system is
independent.  Unlike police departments,
the courts don’t have mayors or the city
council looking over their shoulders.
They have much more freedom and power
than almost any part of the executive
branch.  A second asset is that judges
think in terms of precedent; they’re will-
ing to be guided.  Finally, drug courts have
received a lot of support and encourage-
ment from the federal government.
Kevin Burke: Another asset, I think, is
the willingness of drug courts to be eval-
uated.  People are no longer prone to
make policy by anecdote.  
Stuart:  I think drug courts appeal to peo-
ple’s desire to have hope.  We have seen
an awful lot of criminal justice programs
in recent years that have not worked and
have become more and more punitive.
With drug courts, people see that we’re
not using leeches to cure disease: we’re
switching to antibiotics.  The mainstream
judicial system is still using leeches.
Newman: I would point to the favorable
political climate as an asset.  The public is
much more receptive to this thing than it
used to be.
Roberts: This is true.  You can talk to
almost any drug court professional in the
country, and be told that there have been
favorable newspaper articles and wide-
spread community support for their drug
courts.
Berman: We also know from public opin-
ion surveys that while citizens may not be
aware of what a drug court is per se, they
do approve of the model’s basic elements.
In very high numbers, they like the idea
of judges reaching out to clinicians and
asking their advice on drug cases and
they approve of court-mandated treat-
ment as opposed to incarceration. 
SPREADING THE WORD
Hartmann: Last summer I visited the Red
Hook Community Justice Center, where
it’s easy to see that all the people who
work at the court are true believers in
what they’re doing.  My question is what
happens when the true believers leave?
Can we talk about how to create and per-
petuate local buy-in?
Berman: Whether it’s a community court
like Red Hook or a drug court or some
other kind of innovation, I think it’s pos-
sible to embed the new values we’re talk-
ing about today in architecture, technol-
ogy, and research benchmarks—all kinds
of things other than personnel.  You’ve
got to try to inoculate yourself against the
inevitability of the first generation leav-
ing.
Valerie Raine: Until recently, drug courts
have been created from the grassroots up,
thanks to entrepreneurial judges and
attorneys.  When drug courts are
imposed from the top down, how will
that change things? As you go to scale, do
you take drug courts and make lots of
them, thereby retaining some control
over the process? Or is what we’re seek-
ing a new approach to judicial conduct?
In which case, shouldn’t our efforts be
focused on inculcating this approach into
judicial decision-making in every court-
room? Of course, the risk is losing con-
trol and having what was once an innov-
ative approach become just another case-
processing mill.  These are difficult ques-
tions that don’t have any easy answers.
Schorr: You’re right to be aware that peo-
ple don’t respond well to being told, “You
have to do this.” I would be very leery of
trying to impose the idea of drug courts
on people who don’t want to implement
them.  But it’s a very different thing to say,
“You have to do what is necessary to
implement an idea you’ve already
endorsed.”  You always have to invent
some part of the innovation on site.  You
can’t manufacture the desire to create
something like a drug court from above.
That’s a recipe for disaster. 
Newman: I wonder whether concepts
like problem-solving courts can only be
carried out if you’re directly involved in
building them yourself.  Can you create a
successful drug court—one that incorpo-
rates a process of mutual trust and buy-in
among such diverse parties as judges,
prosecutors, and defense attorneys—
without having everyone build it from the
beginning? 
Roberts: I think it all goes back to train-
ing.  It can be done.  The Department of
Justice assembles training programs to
help people plan drug courts, and we’ve
seen the different stakeholders arrive and
shake hands with each other because it’s
the first time they’ve met.  Some are long-
time enemies.  We watch them go
through a process of learning to appreci-
ate each other’s point of view, and devel-
oping the rudimentary skills of behaving
like a team when they go back home.
Newman: I was part of one of those train-
ing teams several years ago.  I was the
hard-hearted prosecutor; our presiding
judge was the hidebound traditionalist.  I
bonded with our drug court judge when I
found out he snores very loudly on air-
planes.  Even workshop travel was part of
the bonding process!  I think transforma-
tive personal experiences among key fig-
ures are essential to institutionalization.
Watson: All the training in the world
won’t make a difference if the site you’ve
chosen can’t operate the program. In try-
ing to spread drug courts, I think you
have to be careful to pick places where
the capacity exists to implement a new
program. 
Schorr: I’m not sure I agree with you on
this point.  I think you start by looking at
places that really need the innovation and
then try to create the infrastructure to sup-
port it.  I would choose a place that’s needy
over a place that’s ready to innovate.
CONCERNS AND OBSTACLES
Hartmann: We’ve talked a lot about how
you go to scale and how you spread the
word about drug courts.  Before we go
any further, I want to make sure every-
body’s had a chance to air their concerns
about the institutionalization of drug
courts.  What makes you nervous here?
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Smith: I’d be concerned about an over-
reliance on arrests as a way of addressing
drug abuse. There’s an infinite supply of
addicted persons out there.  The more
capacity you create, the more cases you’re
going to have.  There may be no way to
get ahead of demand.  I worry that in cre-
ating drug courts, we may be holding
ourselves back from coming up with
other solutions to the problem.
Newman: I don’t really share your con-
cern.  The idea that a judge in a drug
court would recruit the police into gath-
ering up fodder for his treatment program
and get them to abandon opportunity
deprivation or some other strategy does-
n’t strike me as real.  In Indianapolis, we
do both.
Adele Harrell: My big concern is that
drug courts don’t fall into the trap of
overselling their promise, something I
think we have to guard against very care-
fully.
Michael Dorf: I agree.  What makes us
think a court can solve a complicated
social problem like drug abuse?  The
1960s and ’70s were the high water mark
of optimism in the judiciary’s ability to
address problems like prison overcrowd-
ing, school segregation, and a lack of
mental health treatment services.  What
we’ve seen in the last 20 years or so is
growing skepticism in judges’ ability to
address broad social issues.  
Roberts:  I think we have enough drug
courts.  What we need are more drug
court clients.  Most drug courts are fairly
small experiments.  Are they dealing with
all the people they could be?
Newman: I have a public safety concern
about allowing more serious criminals to
be eligible for drug court.  I get letters
from inmates asking that I let them out
early so they can continue their walk with
Jesus.  My feeling is that Jesus can walk in
a reformatory just as well as outside, and
so too can drug treatment. 
Burke: I think there’s a need to continue
to explain to the 25,000 trial judges
around the country that a drug court is an
enjoyable assignment.  Without that buy-
in, you won’t be able to build momentum
to expand drug courts.  Judges also need
cover, because this is a profession that
doesn’t encourage risk-taking and falling
flat on your face.  
Dorf: Another potential problem with
going to scale is that drug courts today
operate by penalty default —they use the
threat of incarceration to get people to
enter the program.  If you go to scale, you
take away that option.  Entering drug
court would no longer be voluntary. 
Smith: I have a slightly different take on
this question.  Today’s innovation is
tomorrow’s conventional wisdom—the
standard operational procedure that’s des-
perately in need of change.  I think we
need to find a way to go to scale that’s
open to constant change, revision, and
discovery.  Otherwise, you just make it
more difficult for the next innovator.
Lane: That’s a very important point.  I
think drug courts are going to fail at some
point.  The question is how much good
we do within that time frame and
whether we’re preparing an end game for
the next innovation to come forward.
TREATMENT
Hartmann: Expanding the drug court
approach will inevitably require new con-
nections with the treatment community.
What kind of challenges are presented by
partnerships with treatment providers?
Burke: Accountability is one challenge.
Drug courts hold the defendants account-
able, but don’t always do a good job of
holding the treatment provider account-
able.
Harrell: I agree.  I think we have a real
issue of quality control.  When you start
dealing with several thousand people
instead of several hundred, you have to
figure out how the courts can set up the
right mechanisms to ensure treatment
quality, and that treatment programs are
holding offenders accountable.  We’re fac-
ing a serious problem with drug treat-
ment capacity right now; some programs
have a staff turnover rate of 50% each
year.
Chico Gallegos: One major problem with
ensuring effective drug treatment is that
many assessment tools don’t take into
account the specific cultures and popula-
tions drug courts are dealing with.
Cultural competence is important among
both treatment providers and court per-
sonnel.
Roberts: Another issue is the question of
where treatment begins and ends.  Drug
courts have expanded the concept of
treatment beyond its traditional defini-
tion.  With drug courts the goal is not
simply to get participants sober, as it
might be in a straight-up treatment pro-
gram, because then you just end up with
a sober criminal.  The idea is to work on
the behavior that is problematic to the
community.  So for drug courts the goal is
not just sobriety but also law-abiding
behavior. 
Harrell: Flexible thinking about treat-
ment is key.  Over the next few years, our
ideas are going to change as knowledge in
the field grows.  The process of being able
to react to and incorporate these changes
in the definition of effective treatment
should be part of how we think about
taking drug courts to scale.  
LEADERSHIP
Hartmann: Where is the leadership going
to come from to expand drug court pro-
grams? Can the judiciary do it by itself?
Daniel Becker: In Utah the leadership for
drug courts originates from a judicial
council that first put in place certain
broad definitions—one being that our
drug courts would be post-plea, and
another being that treatment would
remain an executive branch function.
Those definitions helped transform the
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“I think drug courts are
going to fail at some
point.  The question is
how much good we do
within that time frame
and whether we’re
preparing an end game
for the next innovation to
come forward.”
— Eric Lane
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drug court judge from rogue status to
legitimacy.  More and more judges have
since begun to express interest in drug
courts.  We are now reaching a critical
mass.  We have enough people engaged in
the programs that we need much more
intensive resources than what we’ve been
working with up to this point.  In our
state, that need has meant bringing the
legislature into play—and as the state
becomes more involved in the adminis-
tration of drug courts, a tension has
developed between accountability and
real innovation.
Hartmann: How valuable is something
like the endorsement of problem-solving
courts by all 50 state court chief judges
and court administrators in convincing
more people that the model is worth the
investment?
Burke: The fact of the matter is that the
Conference of Chief Justices is a pretty
conservative group.  This may be the first
time they’ve passed an endorsement that
is pro-active in nature, and it has been a
great help in getting people’s attention.
As soon as it was passed, I went back to
our judicial council in Minnesota and
was able to argue that it was time to move
our drug courts away from “pilot” status.
Stuart: Judicial support is obviously key,
but it seems inevitable that state court
systems will have to devise a strategy for
approaching the state legislature.  Federal
grant money alone won’t bring drug
courts to scale over the next five years. 
William Vickrey: In California, we have
been fortunate to get the legislature to
fund a separate committee to serve as the
institutional voice on the planning, advo-
cacy, and guidance of drug courts.  We
also have legislation, initiated by the
courts, that created a joint committee of
the Department of Alcohol and Drugs and
the judiciary to oversee drug court fund-
ing. 
Becker: In Utah, we’ve passed a statute
allocating 13% of every dollar of state
funding dedicated to drug court to gen-
eral court operations—to be spent by the
judiciary, and 87% to testing, treatment,
and case management—to be spent by
the Department of Human Services. I pre-
dict that states that successfully redirect
federal money for substance abuse and
treatment into the drug court arena will
be the frontrunners in drug court institu-
tionalization.
Raine: That’s a critical issue.  Health and
Human Services block grants bring huge
amounts of funding to state alcohol and
drug agencies.  Going to scale will be next
to impossible without involving the com-
missioners of these agencies.   
Hartmann: Scott, if you were the czar of
drug courts in Indiana, what would you
want from your state legislature?
Newman: I think it’s important to be care-
ful how you define what’s being taken to
scale.  A bill in Indiana has proposed cod-
ifying the ten components of drug courts
into law.  While I understand the urge, I
don’t think it’s appropriate.  I would
instead structure the law to create an
intermediary body that would help certify
drug courts as well as provide incentives
for their implementation.  When Indiana
created public defender commissions, for
example, we allowed counties to tap into
additional state funds if they had estab-
lished a legitimate program.  We pre-
served for each county the ability to cre-
ate, within broad parameters, qualify for
matching funds, and work with an inter-
mediary that was responsible for articu-
lating standards.  This approach avoids
some of the problems of bureaucracy.  
Dorf: On that note, I think one of the
central challenges of going to scale is to
have “bigness” and coordination without
bureaucracy—and that’s where the idea of
an intermediary comes from.  An inter-
mediary can assess what’s happening in
the field; gather detailed, accurate infor-
mation from local players; develop some
sense of what the best practices are; and
relay that information back to the players.
This is the kind of institutional architec-
ture I think you need if you want to move
from a system based on charisma to one
based on standards and principles.
Hartmann: Lee, let me put you on the
spot.  Institutionalization versus bureau-
cratization.  What’s the difference?
Schorr: If I knew, I would have written
another book about it!  That’s a very hard
question to answer.  The term bureau-
cracy carries a negative connotation
today that it didn’t have in the Progressive
Era.  I think when we use a word like
institutionalize, what we’re suggesting is
that we find the time and opportunity to
allow for local variation and to move
away from excessive rigidity.
Newman: To me, bureaucracy creates a
coercive style of leadership that forces
other people to act in a certain way.
Institutionalization is a motivational style
of leadership, which gets people inspired
and allows them to build their own teams
and create programs with some flexibility.
You have to move beyond that to a system
less dependent on leadership, or you’ll
end up with a coercive situation in which
other people feel they have to act a cer-
tain way.  I think we all favor the kind of
leadership that allows people some flexi-
bility. 
LOOKING AHEAD
Hartmann: Where do you want drug
courts to be in five years, and what single
significant investment would you make
to get them there?
Traficanti: In New York, my goal is to dis-
appear by 2003, leaving in place the
resources and infrastructure necessary for
local sites to carry the drug court idea for-
ward. In five years, I would like to see—
in every state and across the country—
the resources available for any defendant,
in any jurisdiction, to go into treatment.
This can be achieved by making it possi-
ble for judges to electronically access
information from the bench, including
available program slots and available
beds.
“In five years, I would
like to see—in every 
state and across the
country—the resources
available for any 
defendant, in any 
jurisdiction, to go into
treatment.  This can be
achieved . . . .”
— Joseph Traficanti, Jr.
Milliken: My goal is for every sentencing
judge to have access to an assessment of
the defendant that allows him to decide
whether to make treatment a part of the
sentence.  In order for that to happen, we
need state funding for treatment for the
adult criminal population.
Smith: I would like to see the idea that
sentencing is a responsibility of the court
over a prolonged period of time gain
wider currency.
Newman: The single most important
investment that drug courts could make is
in management information systems.
Building more uniform operating systems
for drug treatment courts would really
advance the ball on institutionalization.  
Becker: I’d like to see less emphasis
placed on drug courts per se, and more
emphasis on making treatment a main-
stream enterprise by developing partner-
ships between courts and state agencies
that oversee treatment. 
Lane: I’d like to find a way to define suc-
cess, figure out how to measure it, and
then invest in the tools to measure it.  We
would then have an opportunity to really
find out what it means for a drug court to
“work.”
Scott: I would love criminal justice practi-
tioners to understand their roles more
broadly than they currently do.
Prosecutors should see themselves as
more than just the chief law enforcement
officers, but also chief lawyers who help
us think about community standards and
public safety.  Judges should see them-
selves not just as decision-makers but as
concerned leaders of the community.
Gallegos: I’d like to see evidence that drug
courts have made inroads in the broader,
loftier goal of rebuilding communities. 
Stuart: I would like to see every court in
my state thinking of itself as a substance
abuse court, and operating with the kind
of consciousness about these issues that
we’ve been talking about today.  The
investment to be made is in the time
needed to talk about what the justice sys-
tem is really doing and whether it’s work-
ing. 
Harrell: I share the vision of making this
a way of doing business across the justice
system, and maybe even fading drug
courts out of existence as their tenets
become embedded in practice. 
Schorr: I feel very envious of all of you
because this is a far better, more rigorous
discussion that I am used to hearing.  And
as I walk away from this table, I think
what’s most exciting is the idea that drug
courts open doors for the court system in
general to become more problem-solving,
in terms of thinking more broadly about
problems and solutions.  
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